WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 31-July-2017 (data as of 19-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 7'7901 Infant (under 12 months) mortality rate: 682
GDP / capita (US$): 30'0411 Child (under 5 years) mortality rate: 942

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 1'221  1'175  1'129  1'084  1'039  614  427  255 
Births 42  41  40  39  38  25  18  12 
Surviving infants 39  38  37  36  35  23  16  10 
Pop. less than 5 years 182  176  171  166  161  102  74  41 
Pop. less than 15 years 456  440  425  410  395  250  183  100 
Female 15-49 years 268  258  248  238  228  138  95  61 

Number of reported cases

(Click for retrospective incidence data for Equatorial Guinea)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  1'699  1'250  13  321  1'190  32 
Mumps
ChartChart
 
Pertussis
ChartChart
  67 
Polio*
ChartChart
 
Rubella
ChartChart
  79  14 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Equatorial Guinea)
Vaccine year result method % card seen                                                
BCG 2010  71  DHS   37  46  35  64  51  53  34 
DTP1 2010  59  DHS   37  42  26  57  47  54  39 
DTP3 2010  41  DHS   37  33  17  45  24  41  32 
DTP4         
IPV1          12 
HepB_BD         
HepB3          33  17  45 
Hib3          33  17  45 
JapEnc         
MCV1          29  26  43  41  34  19 
MCV2         
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2010  34  DHS   37  30  27  52  40  40  32 
Rota1         
RotaC         
RCV1         
TT2plus 2010  63  DHS   37  23  23  36  31  30  30 
PAB          27  61 
VAD1          26 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Equatorial Guinea)
BCG
ChartChart
  48  48  56  64  66  73  94 
DTP1
ChartChart
  40  28  59  49  56  64  96 
DTP3
ChartChart
  19  16  20  24  34  77 
HepB3
ChartChart
  19  16  20 
HepB_BD
 
Hib3
ChartChart
  19  16  20 
IPV1
  12 
MCV1
ChartChart
  30  27  44  42  35  51  88 
MCV2
 
PCV3
 
Pol3
ChartChart
  20  17  24  30  30  41  75 
RCV1
 
RotaC
 
YFV
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
97 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric birth; Yes From October 2017
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 years; Yes
VitaminA 6, 12 months; Yes
YF 9 months; Yes From April 2017

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  Yes  Yes  Yes  Yes 
What years does the MYP cover? number NA    NA  2009-2013  2009-2013  2009-2013  2009-2013 
Nº of districts with microplans that include activities to raise immunization coverage number 18  18  18  18  16  18 

System performance

Total Nº districts in country number   18  18  18  18  18  18 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100%   11  17 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100%   11 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 64  100  100  80  100  100  59 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.